Regulatory Status of Medicinal Products for Human Beings in the European Union. The Role of Generic Products

ISSN： 1043-6618

Source： Pharmacological Research, Vol.34, Iss.1, 1996-07, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the regulatory controls for medical devices and medicinal products

By DB J.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 3, 2001-06 ,pp. : 125-130

Adis International

Access to resources Recommend Favorite

Analysis of 312 studies of investigational medicinal products in healthy subjects to assess the impact of the European Union Clinical Trials Directive

By Malcolm B. Steve W.

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 4, 2002-08 ,pp. : 179-183

Adis International

Access to resources Recommend Favorite

Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965–2007: case Finland

International Journal Of Health Planning And Management, Vol. 30, Iss. 3, 2015-07 ,pp. : 260-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmaceutical biotechnology products approved within the European Union

By Walsh G.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval

By Apolone G.

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 187-195

Adis International

Access to resources Recommend Favorite